STDs and STIs remain a pressing health and public concern that sometimes affects interpersonal relationship. Miramistin is commonly used in venereology in order to reduce risk of getting STDs for both men and women.
Sexually transmitted diseases keep breaking world record with a number of patients. Every year nearly 340 million people up to 49 years are diagnosed with different types of STDs. Experts recognize more than 30 types of sexually transmitted bacteria that cause infections such as syphilis, gonorrhea, genital herpes and candidiasis, chlamydia, trichomoniasis, mycoplasmosis. And, unfortunately, this list continues to grow.
What is So Dangerous about STDs?
It is important to note that quite a number of STIs do not have obvious signs or symptoms right after the exposure. Many of them are asymptomatic, so an infected person can become a silent spreader. Like any other diseases, STDs require an early detection and treatment, otherwise they may lead to a serious, life-threatening complications, for instance, STDs can increase risk of contracting HIV and HPV can cause cervical and other cancers. Gonorrhea, chlamydia and trichomoniasis are prime examples of genital infections that may cause pelvic inflammatory disease. Also having an STI during pregnancy can hurt the unborn baby’s health. It may cause premature labor, low birth weight, developmental problems, brain damage or even stillbirth.
Efficacy of Miramistin against STDs.
Miramistin® has a wide antimicrobial effect and can be used for prevention of sexually transmitted diseases (i.e. syphilis, gonorrhea, chlamydia, genital herpes and candidiasis) for both men and women 1.
Miramistin® is shown to be active against many bacteria, complex viruses and fungi. That makes Miramistin® an effective solution not only for prevention STIs but in complex treatment of genitourinary disorders (e.g. urethritis, urethroprostatitis, vulvovaginitis) in males and females 1.